Company Filing History:
1 out of 432 
1 out of 4 Years Active: 2016
Title: The Innovative Work of Takefumi Ishidao in NK Cell Amplification
Introduction
Takefumi Ishidao, based in Minato-ku, Japan, is an accomplished inventor known for his significant contributions to the field of immunotherapy. With a focus on natural killer (NK) cells, his innovation aims to advance the effectiveness of adoptive immunotherapy by providing a method to amplify these crucial immune cells.
Latest Patents
Takefumi Ishidao holds a patent for a "Method for amplifying NK cells." This novel technique addresses the need for an effective way to increase the population of NK cells in vitro, enabling the preparation of an optimal quantity of these cells for therapeutic uses. The patented method involves several steps, including the preparation of a cell population containing NK cells, the removal of T cells, and the cultivation of the remaining cells in a medium enriched with a specific concentration of interleukin-2 (IL-2). This innovative approach may also include the removal of hematopoietic progenitor cells from the population, enhancing the potential application of NK cells in immunotherapy.
Career Highlights
Takefumi Ishidao has made significant strides in his career through his work at various reputable institutions. He has been associated with Kyushu University, where he expanded his knowledge and expertise in the field of immunology. Additionally, his role at Tella, Inc. allowed him to translate his research into practical applications and further his impact in the biotech sector.
Collaborations
Throughout his career, Takefumi has collaborated with prominent colleagues, including Yoshikazu Yonemitsu and Yui Harada. These partnerships have fostered a collaborative environment that has propelled research endeavors focused on the capabilities of NK cells and their use in therapeutic settings.
Conclusion
Takefumi Ishidao's innovative methods for amplifying NK cells represent a significant advancement in the realm of adoptive immunotherapy. His dedication to enhancing immune responses through scientific research has positioned him as a key inventor in this important field. As the demand for effective immunotherapy treatments grows, Ishidao's contributions will likely continue to influence the future of cancer treatment and beyond.